H1N1 on the Rise: Should India Be Worried?

A fever, cough and body ache may sound like an ordinary seasonal flu. But with H1N1 cases rising in several parts of India, the familiar virus is once again making headlines. Delhi alone has reported more than 1,700 H1N1 cases this year, while other cities and states are also reporting increased influenza activity.

So, should we be worried?

The answer is: concerned, but not alarmed.

Why are cases increasing?

 The rise in H1N1 cases is likely linked to changing weather patterns, particularly the humid and fluctuating conditions that can favour the transmission of respiratory viruses. Influenza viruses continue to circulate in the community and their activity naturally rises and falls with seasons and local environmental conditions.

But there is another reason why influenza deserves particular attention: it is a constantly evolving virus. Influenza undergoes two important types of antigenic change: antigenic drift and antigenic shift.

Antigenic drift refers to small, gradual genetic changes that occur as the virus replicates. Over time, these changes can help the virus partially escape existing immunity, allowing influenza to cause repeated seasonal outbreaks and making regular review and updating of influenza vaccines necessary.

Antigenic shift, on the other hand, is a much bigger and rarer change. It occurs when influenza A viruses exchange genetic material and a virus with substantially different surface antigens emerges. Because the population may have little or no pre-existing immunity to such a virus, an antigenic shift can potentially lead to a large outbreak or even a pandemic.

This is what makes influenza a concerning infection an important public-health concern. However, the reassuring news this season is that there is currently no evidence of a new H1N1 strain driving the increase in India. ICMR has stated that the H1N1 viruses currently circulating belong to strains that have been in circulation since 2025 and are well matched with the vaccine strains recommended for the Northern Hemisphere.

Who needs to be more careful?

For most healthy individuals, influenza is usually self-limiting. However, the risk of complications is higher among young children, older adults, pregnant women and people with chronic illnesses including asthma, diabetes, heart or lung disease and those with weakened immunity.

For these groups, what may begin as “just flu” can sometimes progress to pneumonia, worsening of underlying diseases or other serious complications.

Know the symptoms

H1N1 can resemble other influenza infections. Common symptoms include:

• Fever
• Cough
• Sore throat
• Runny or blocked nose
• Headache
• Body aches
• Extreme tiredness

Most people recover with appropriate care. However, breathing difficulty, chest pain, persistent high fever, confusion, severe weakness, dehydration or worsening symptoms after initial improvement should prompt medical attention, particularly in high-risk individuals.

Importantly, symptoms alone cannot reliably tell us whether an illness is H1N1 or another respiratory infection. Testing is decided according to the clinical situation and public-health requirements.

What about the flu vaccine?

This is perhaps the most important question during the current surge.

Yes, influenza vaccines remain relevant.

But there is an important concept to understand: flu vaccines are not designed to protect against every influenza virus that could ever exist. Influenza viruses continually evolve, which is why vaccine composition is reviewed and updated regularly.

For the 2026–27 Northern Hemisphere season, World Health Organization (WHO) has recommended an H1N1pdm09-like virus along with H3N2 and influenza B components for seasonal influenza vaccines.

This means that vaccination is designed around the influenza viruses that surveillance systems expect to circulate.

And this is where the idea of a “new strain” becomes important.

If a substantially different strain emerges and is poorly matched to existing vaccine strains, it could become a great public – health concern and may require reassessment of vaccine composition.

Vaccination is particularly important for people at higher risk of complications. However, it should not be viewed as a guarantee against infection. Its major public-health benefit is reducing the risk of severe illness, complications and influenza-related hospitalization.

 What should we do now?

There is no need to panic or unnecessary disruption to everyday life. But simple precautions matter.

Stay home when sick, avoid close contact with vulnerable people, cover coughs and sneezes, wash hands regularly and improve ventilation in indoor spaces. Wearing a mask in crowded or poorly ventilated settings can provide additional protection.

People at higher risk of complications should discuss seasonal influenza vaccination with their healthcare provider.

And if symptoms become severe or occur in someone at high risk, do not wait for the illness to become serious before seeking medical advice.

India’s current H1N1 situation is a reminder that influenza remains an important public-health challenge. The right response is neither fear nor complacency.

For now, available evidence points towards increased seasonal influenza activity rather than the emergence of a new H1N1 strain. However, influenza deserves continued attention because of its ability to evolve and occasionally undergo major antigenic changes.

Watch the numbers. Trust surveillance. Vaccinate appropriately. Protect the vulnerable. And seek timely care.